Table 2. Multivariable Cox Proportional Hazards Regression Models for All-Cause Mortality Using Intent-to-Treat and As-Treated Approaches to MOUD Exposure for IDU-IE–Associated Discharges From July 2011 to June 2015a.
Characteristic | Hazard Ratio (95% CI) | ||
---|---|---|---|
Model 1: MOUD within 3 mo after IDU-IE | Model 2: monthly MOUD receipt after IDU-IE | Model 3: monthly after IDU-IE, including month of discontinuation | |
MOUD | 1.29 (0.61-2.72) | 0.30 (0.10-0.89) | 0.39 (0.15-1.00) |
MOUD 3 mo before admission | 0.77 (0.34-1.75) | 1.35 (0.65-2.81) | 1.33 (0.62-2.82) |
Age, y | |||
18-34 | 0.24 (0.11-0.51) | 0.26 (0.12-0.55) | 0.26 (0.12-0.55) |
35-49 | 0.60 (0.34-1.06) | 0.62 (0.35-1.10) | 0.62 (0.35-1.1) |
50-64 | 1 [Reference] | 1 [Reference] | 1 [Reference] |
Female | 0.80 (0.45-1.42) | 0.80 (0.45-1.43) | 0.80 (0.42-1.58) |
Elixhauser Comorbidity Index | 1.03 (0.97-1.09) | 1.03 (0.97-1.09) | 1.01 (0.96-1.08) |
Mental illness | 0.77 (0.39-1.49) | 0.81 (0.42-1.57) | 0.81 (0.42-1.58) |
Homelessness | 0.60 (0.32-1.6) | 0.60 (0.31-1.14) | 0.61 (0.32-1.2) |
Abbreviations: IDU-IE, injection drug use–associated infective endocarditis; MOUD, medication for opioid use disorder.
Homelessness, major mental illness, and Elixhauser Comorbidity Index covariates were defined as evidence during any part of the study period not only before the index IDU-IE–related hospitalization. There were 61 deaths in each model.